Vernalis (VER)

 

Latest News

Notice of Annual Report and AGM

Miscellaneous medium priority announcements

Total Voting Rights

Notification of a change in the total number of voting rights

Block listing Interim Review

Six monthly notification by a company issuing securities on aregular basisNotification of a company’s annual report & accounts

Vernalis sales beat market expectations

Vernalis reported revenue of 20.8m (2016: 12m), which was ahead of market expectations in the year to 30 June 2017. US CO...

All News

DateHeadlineSource
02-11-17Notice of Annual Report and AGMRNS
31-10-17Total Voting RightsRNS
29-09-17Block listing Interim ReviewRNS
12-09-17Vernalis sales beat market expectationsStockMarketWire
12-09-17Results Announcement for the Year Ended 30/06/2017RNS
07-08-17FDA Issues Complete Response Letter on CCP-08 NDARNS
28-07-17Broker Forecast - Cantor Fitzgerald issues a broker note on Vernalis PLCStockMarketWire
18-07-17Vernalis anticipates sales to be expectationsStockMarketWire
18-07-17Year-End Trading Update and Notice of ResultsRNS
30-06-17Total Voting RightsRNS
31-05-17Total Voting RightsRNS
28-04-17Total Voting RightsRNS
26-04-17Vernalis and Servier announce three milestonesStockMarketWire
26-04-17Servier and Vernalis announce 3 milestonesRNS
21-04-17Broker Forecast - Panmure Gordon issues a broker note on Vernalis PLCStockMarketWire
21-04-17Broker Forecast - Stifel issues a broker note on Vernalis PLCStockMarketWire
21-04-17FTSE struggles as dominant blue-chips fall StockMarketWire
21-04-17FTSE ahead as miners up with industrial metals pricesStockMarketWire
21-04-17Vernalis to resubmit NDA to US FDA for drug CCP-07StockMarketWire
21-04-17Vernalis receives $2 million milestone paymentRNS
21-04-17FDA Issues Complete Response Letter on CCP-07 NDARNS
04-04-17Broker Forecast - Stifel issues a broker note on Vernalis PLCStockMarketWire
29-03-17Block listing Interim ReviewRNS
20-03-17Broker Forecast - N+1 Singer issues a broker note on Vernalis PLCStockMarketWire
06-03-17Vernalis, Servier in new drug discovery collaborationStockMarketWire
06-03-17New drug discovery collaboration with ServierRNS
28-02-17Total Voting RightsRNS
21-02-17Unaudited interim results for 6 months to 31/12/16RNS
14-02-17Broker Forecast - Stifel issues a broker note on Vernalis PLCStockMarketWire
14-02-17Achievement of a $3m milestone payment from CorvusRNS
30-01-17Vernalis schedules interimsStockMarketWire
30-01-17Notice of Results for Six Months Ended 31/12/2016RNS
25-01-17Versarien Plc to present at the Shares Spotlight Evening in London on 9 February 2017StockMarketWire
21-12-16Vernalis says FDA accepts CCP-08 NDA for full reviewStockMarketWire
21-12-16FDA accepts CCP-08 NDA for full reviewRNS
01-12-16Broker Forecast - Panmure Gordon issues a broker note on Vernalis PLCStockMarketWire
01-12-16Vernalis Results of Annual General MeetingRNS
01-12-16Vernalis says business progressing in line with viewsStockMarketWire
01-12-16AGM StatementRNS
11-11-16AIM shares touched by the 'Trump effect' Interactive Investor

RSS feeds

  • Editorial news feed for LSE:VER Editorial
  • Regulatory news feed for LSE:VER Regulatory

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account